TCTMD3h
ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients
Among successful revascularizations, there was a hint of better outcomes compared with OMT, but the data need confirmation.
Le Lézard21h
New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings
New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca's TAGRISSO® (osimertinib), as monotherapy and as the backbone for ...
Healio8h
Patients with COPD plus depression or anxiety experience greater disease burden
Patients with COPD plus a depression/anxiety disorder had poorer scores related to disease burden and health-related quality of life, according to data published in Chronic Obstructive Pulmonary ...